13.4: Antibody quantification and titration Antibody quantification and titration is performed in RCI laboratories on patients’ samples, to support the prediction and management of HDFN …
13.3: Pre-transfusion testing 13.3.1: Resolution of anomalous grouping ABO grouping is the most important pre-transfusion serological test performed. Fully automated ABO and D…
13.2: Sample acceptance and labelling Visual inspection to determine the suitability for testing should consider the following in relation to the equipment, methods and samples used:…
13.1: Scope These specifications provide guidance on the tests required for investigations performed on patient samples in red cell immunohaematology (RCI) laboratories in UK Blood Trans…
5.12: Donor compensation The Blood Transfusion Services should have established procedures to ensure that any claim by a donor for compensation for any injury or loss allege…
5.11: Adverse events All adverse events must be documented and reported according to standard protocols. All bag/harness defects (e.g. pinhole leaks) must be recorded and all de…
5.9: Information to be provided to the donor post-donation The donor must be provided with information on care of the venepuncture site and requested to report any illness o…
5.8: Component donation by apheresis Guidance for collection procedures is identical to that for normal whole blood donations except for the points listed below.
5.7: Whole blood donation If necessary, the donor should be asked to open and close his/her hand slowly every 10–12 seconds to encourage a free flow of blood.
5.6: Performance of the venepuncture Venepuncture should only be undertaken by authorised and trained personnel. Items used for venepuncture must be st…
5.5: Preparation of the blood pack 5.5.1: Whole blood pack The blood collection set must be in date and inspected for any defects. These are sometimes obscured by…
5.4: Preparation of the venepuncture site Blood must be drawn from a suitable vein in the antecubital fossa in an area that is free of skin lesions. The veins can be made mo…
5.3: Haemoglobin screening A validated haemoglobin screen should be applied to all donors prior to donation. The objective is to ensure that prior to …
5.2: Information to be obtained from donors by Blood Establishments at every donation 5.2.1: Donor identification Donors must positively identify themselves by volunteering th…
5.1: Information to be provided to prospective donors of blood or blood components The following information must be provided to all donors: Accurate educational material…
4.8: Protection and preservation of donation quality All blood and components must be transported, tested and stored in accordance with the specificat…
4.6: Records It is strongly recommended that all records pertaining to donor and donation identity be entered and maintained in an electronic format which can be accessed re…
4.5: Labelling Session staff must ensure that a set of labels with a unique number is assigned to each donation and that the same unique number appears on the donor se…
22.9: Labelling, packaging, transportation and release The mandatory requirements for these are described in the HTA’s Guide to Quality and Safety Assurance for Human Tissue and Cells fo…
22.8: Requirements for the timing of testing Please see Annex 7 for guidance relating to the timing of testing for different categories of HPC.
22.7: Testing of haemopoietic progenitor cell donors and components Infectious disease marker testing, ABO and RhD typing and clonogenic assays must be done in accordance with the HTA gu…
Type the first few letters of what you are looking for until it appears below. The topic you are taken to will contain the relevant information you are looking for.